Compare IDYA & SEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IDYA | SEB |
|---|---|---|
| Founded | 2015 | 1918 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Farming/Seeds/Milling |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.6B | 3.8B |
| IPO Year | 2019 | 1994 |
| Metric | IDYA | SEB |
|---|---|---|
| Price | $32.85 | $3,955.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 16 | 0 |
| Target Price | ★ $52.29 | N/A |
| AVG Volume (30 Days) | ★ 840.4K | 7.3K |
| Earning Date | 11-03-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.23% |
| EPS Growth | 61.90 | ★ 467.71 |
| EPS | N/A | ★ 283.99 |
| Revenue | $218,710,000.00 | ★ $5,809,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $189.87 | N/A |
| P/E Ratio | ★ N/A | $14.02 |
| Revenue Growth | ★ 3024.43 | 7.99 |
| 52 Week Low | $26.81 | $3,140.01 |
| 52 Week High | $42.68 | $5,989.37 |
| Indicator | IDYA | SEB |
|---|---|---|
| Relative Strength Index (RSI) | 27.61 | 40.35 |
| Support Level | $29.74 | $3,864.03 |
| Resistance Level | $35.14 | $4,143.09 |
| Average True Range (ATR) | 1.29 | 110.70 |
| MACD | -0.43 | 1.43 |
| Stochastic Oscillator | 5.25 | 19.09 |
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 (Werner Helicase), IDE161 (PARG), and IDE705 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.